KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Inventory (2016 - 2025)

Historic Inventory for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $27.8 million.

  • Biolife Solutions' Inventory fell 1353.06% to $27.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.8 million, marking a year-over-year decrease of 1353.06%. This contributed to the annual value of $29.0 million for FY2024, which is 680.68% up from last year.
  • Latest data reveals that Biolife Solutions reported Inventory of $27.8 million as of Q3 2025, which was down 1353.06% from $27.7 million recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' Inventory registered a high of $43.4 million during Q1 2024, and its lowest value of $11.7 million during Q1 2021.
  • Moreover, its 5-year median value for Inventory was $30.2 million (2022), whereas its average is $31.5 million.
  • Per our database at Business Quant, Biolife Solutions' Inventory skyrocketed by 16905.86% in 2021 and then tumbled by 3650.44% in 2025.
  • Biolife Solutions' Inventory (Quarter) stood at $28.3 million in 2021, then rose by 23.14% to $34.9 million in 2022, then fell by 22.18% to $27.2 million in 2023, then increased by 6.81% to $29.0 million in 2024, then dropped by 4.09% to $27.8 million in 2025.
  • Its last three reported values are $27.8 million in Q3 2025, $27.7 million for Q2 2025, and $27.6 million during Q1 2025.